---
$id: https://graph.org.ai/products/commodity/51151520
$type: Product
source: UNSPSC
code: "51151520"
title: "Aclatonium napadisilate"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aclatonium napadisilate

**UNSPSC Code**: 51151520
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholinergic agonist with the molecular formula 2C10H20NO4.C10H6O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YX23434YHQ, chemically known as 2-(2-(acetyloxy)-1-oxopropoxy)-n,n,n-trimethylethanaminium, 1,5-naphthalenedisulfonate (2:1) but generally known as aclatonium napadisilate, which bears US NIH Compound Identifier 41315. European Medicines Agency schedules Aclatonium napadisilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05244MIG. The term ACLATONIUM NAPADISILATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). Most nations schedule aclatonium napadisilate under HS 29239000 and SITC 51481. As of Q4 2014, ACLATONIUM NAPADISILATE remains the US FDA Preferred Term for this commodity. Aclatonium napadisilate bears US NLM identifiers UMLS ID C0076758 and NCI Concept Code C91037. SMILES: CC(C(=O)OCC[N+](C)(C)C)OC(=O)C.CC(C(=O)OCC[N+](C)(C)C)OC(=O)C.C1=CC2=C(C=CC=C2S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-].

